Case Report: A case of radioactive iodine-refractory thyroid cancer accompanying cervical lymph node metastasis treated with US-guided RFA combined with (125)I seed implantation

BACKGROUND: Local control of metastases is critical to improving the life quality of patients with radioactive iodine-refractory (RAIR) thyroid cancer accompanying regional lymph node metastasis. CASE REPORT: The reported patient suffered from RAIR thyroid cancer accompanying poorly controlled cervi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhai, Yuanpeng, Shao, Yu, Li, Qian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751489/
https://www.ncbi.nlm.nih.gov/pubmed/36531018
http://dx.doi.org/10.3389/fonc.2022.987484
_version_ 1784850483118080000
author Zhai, Yuanpeng
Shao, Yu
Li, Qian
author_facet Zhai, Yuanpeng
Shao, Yu
Li, Qian
author_sort Zhai, Yuanpeng
collection PubMed
description BACKGROUND: Local control of metastases is critical to improving the life quality of patients with radioactive iodine-refractory (RAIR) thyroid cancer accompanying regional lymph node metastasis. CASE REPORT: The reported patient suffered from RAIR thyroid cancer accompanying poorly controlled cervical lymph node metastasis. The patient’s lesions were controlled through (125)I seed implantation combined with ultrasound-guided radio-frequency ablation (US-guided RFA). Such a combination therapy has not been reported to date. CONCLUSION: This study found US-guided RFA combined with (125)I seed implantation to be safe and effective for the control of cervical local metastases in patients with RAIR thyroid cancer.
format Online
Article
Text
id pubmed-9751489
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97514892022-12-16 Case Report: A case of radioactive iodine-refractory thyroid cancer accompanying cervical lymph node metastasis treated with US-guided RFA combined with (125)I seed implantation Zhai, Yuanpeng Shao, Yu Li, Qian Front Oncol Oncology BACKGROUND: Local control of metastases is critical to improving the life quality of patients with radioactive iodine-refractory (RAIR) thyroid cancer accompanying regional lymph node metastasis. CASE REPORT: The reported patient suffered from RAIR thyroid cancer accompanying poorly controlled cervical lymph node metastasis. The patient’s lesions were controlled through (125)I seed implantation combined with ultrasound-guided radio-frequency ablation (US-guided RFA). Such a combination therapy has not been reported to date. CONCLUSION: This study found US-guided RFA combined with (125)I seed implantation to be safe and effective for the control of cervical local metastases in patients with RAIR thyroid cancer. Frontiers Media S.A. 2022-12-01 /pmc/articles/PMC9751489/ /pubmed/36531018 http://dx.doi.org/10.3389/fonc.2022.987484 Text en Copyright © 2022 Zhai, Shao and Li https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Zhai, Yuanpeng
Shao, Yu
Li, Qian
Case Report: A case of radioactive iodine-refractory thyroid cancer accompanying cervical lymph node metastasis treated with US-guided RFA combined with (125)I seed implantation
title Case Report: A case of radioactive iodine-refractory thyroid cancer accompanying cervical lymph node metastasis treated with US-guided RFA combined with (125)I seed implantation
title_full Case Report: A case of radioactive iodine-refractory thyroid cancer accompanying cervical lymph node metastasis treated with US-guided RFA combined with (125)I seed implantation
title_fullStr Case Report: A case of radioactive iodine-refractory thyroid cancer accompanying cervical lymph node metastasis treated with US-guided RFA combined with (125)I seed implantation
title_full_unstemmed Case Report: A case of radioactive iodine-refractory thyroid cancer accompanying cervical lymph node metastasis treated with US-guided RFA combined with (125)I seed implantation
title_short Case Report: A case of radioactive iodine-refractory thyroid cancer accompanying cervical lymph node metastasis treated with US-guided RFA combined with (125)I seed implantation
title_sort case report: a case of radioactive iodine-refractory thyroid cancer accompanying cervical lymph node metastasis treated with us-guided rfa combined with (125)i seed implantation
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751489/
https://www.ncbi.nlm.nih.gov/pubmed/36531018
http://dx.doi.org/10.3389/fonc.2022.987484
work_keys_str_mv AT zhaiyuanpeng casereportacaseofradioactiveiodinerefractorythyroidcanceraccompanyingcervicallymphnodemetastasistreatedwithusguidedrfacombinedwith125iseedimplantation
AT shaoyu casereportacaseofradioactiveiodinerefractorythyroidcanceraccompanyingcervicallymphnodemetastasistreatedwithusguidedrfacombinedwith125iseedimplantation
AT liqian casereportacaseofradioactiveiodinerefractorythyroidcanceraccompanyingcervicallymphnodemetastasistreatedwithusguidedrfacombinedwith125iseedimplantation

Ejemplares similares